Owing to the propensity for visual loss, immunosuppressive treatment in the form of systemic and/or local therapy is often required for the management of noninfective intermediate and posterior ...

September 28, 2010 — The US Food and Drug Administration (FDA) has approved a dexamethasone 0.7 mg intravitreal implant (Ozurdex; Allergan, Inc) for the treatment of noninfectious ocular inflammation ...

This page lists all known medications that could potentially lead to 'Posterior uveitis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Treatment with a single intravitreal injection of Yutiq can significantly reduce recurrence rates of ...

Significantly fewer patients in the fluocinolone acetonide intravitreal implant group experienced recurrence of uveitis at 6 months compared with the sham group. The Food and Drug Administration (FDA) ...

Objectives There is evidence that pars plana vitrectomy (PPV) has a beneficial effect on the clinical course of chronic endogenous posterior uveitis (EPU) possibly by physically removing any resident ...

Uveitis is a broad term for many problems with your eye. What they have in common is eye inflammation and swelling that can damage eye tissues. That damage can lead to poor vision or blindness. About ...

An open-label clinical trial including seven patients (12 eyes) with posterior uveitis refractory to conventional treatment regimens with corticosteroids and at least one immunosuppressive agent.

Please provide your email address to receive an email when new articles are posted on . KOLOA, Hawaii – Effective uveitis treatment calls for zero tolerance of visually threatening ocular inflammation ...

It is rare for patients with chronic lymphocytic leukemia (CLL) to present with ocular involvement, but a mutational test could help clinicians identify patients more quickly. Testing for myeloid ...

Posterior segment non-infectious uveitis (NIPU) is a chronic, inflammatory disease affecting the posterior segment of the eye, often involving the retina, and is a leading cause of blindness in ...